Skip to content

Jim Lagopoulos

17 papers in the library · 64 citations · publishing 2009-2025

Papers

Sort Most recent Most cited

Psilocybin in the real world: Regulatory, ethical, and operational challenges in Australia’s clinical landscape

Australian & New Zealand Journal of Psychiatry December 17, 2025 Megan Dutton, Paul Schwenn, Jules S Mitchell et al. 1 citation

Australia’s reclassification of psilocybin as a Schedule 8 substance for treatment-resistant depression represents a significant shift in psychiatric policy. While this regulatory change positions Australia as a global leader in psychedelic medicine, its implementation has revealed substantial challenges. This article critically examines the regulatory, ethical and operational complexities...

DOI: 10.1177/00048674251398677 (opens in new tab) Psilocybin Mental health Context archaeology Novelty +6

Ketamine in psychiatry: Ethical imperatives in harnessing a controversial yet promising therapy

Australian & New Zealand Journal of Psychiatry December 11, 2025 Adem T. Can, Jim Lagopoulos, Paul B Fitzgerald et al. 2 citations

Ketamine has emerged as a rapid-acting intervention for treatment-resistant psychiatric disorders, generating both enthusiasm and unease. While evidence demonstrates robust antidepressant, anxiolytic and anti-suicidal effects, ketamine also carries risks, including dissociation, dependence and uncertain long-term safety. Its reputation as a recreational drug further complicates clinical...

Molecular pathways of ketamine: A systematic review of immediate and sustained effects on PTSD.

Psychopharmacology June 1, 2025 Nathan J Wellington, Ana P. Bouças, Jim Lagopoulos et al. 16 citations

Existing studies predominantly focus on the molecular and neurobiological mechanisms underlying Ketamine's acute treatment effects on post-traumatic stress disorder (PTSD). This emphasis has largely overlooked its sustained therapeutic effects, which hold significant potential for the development of targeted interventions. This systematic review examines the pharmacokinetic and pharmacodynamic...

Methylome and transcriptome functional analysis identifies key biomarkers in ketamine’s sustained therapeutic effect on PTSD

medRxiv May 27, 2025 Nathan J Wellington, Ana Paula Bouças, Paul Schwenn et al. 1 citation preprint

Abstract Background Ketamine has emerged as a rapid-acting therapeutic option for post-traumatic stress disorder (PTSD); however, its ability to sustain long-term therapeutic outcomes remains poorly understood. Identifying molecular biomarkers predictive of a sustained response to ketamine may enhance personalised treatment strategies. This study investigates the epigenetic and transcriptomic...

Temporal Immune Effects of Oral Ketamine on PTSD: Transcriptomic Evidence of Short-Term Inflammation Suppression and Long-Term Immune Remodelling

medRxiv Preprint Server May 26, 2025 Nathan J Wellington, Bonnie L. Quigley, Ana P. Bouças et al. preprint

Ketamine’s rapid acting symptom relief make it a promising intervention for PTSD. However, the mechanisms driving its long-term efficacy over weeks and months remain poorly understood. This study investigated the short-and long-term impacts on gene expression of a six-week subanesthetic oral ketamine trial in 23 PTSD participants (9 males, 14 females). Peripheral Blood Mononuclear Cells (PBMCs)...

DOI: 10.1101/2025.05.26.25328370 (opens in new tab) Full text (opens in new tab) Ketamine therapy PTSD Treatment Mental health treatment Ketamine For PTSD +14

Blood biomarker changes and relationships after low dose oral ketamine treatment for post-traumatic stress disorder (PTSD)

medRxiv Preprint Server March 2, 2025 Bonnie L. Quigley, Emerald Orr, Sophie Kafka et al. preprint

Ketamine has been investigated as a treatment alternative for PTSD for the last 20 years, yet there have been virtually no reports of biological changes or biomarker characterisation related to treatment. To address this significant gap, this study analysed blood samples from 25 participants with PTSD who took part in an open-label 6-week trial of low dose oral ketamine treatment. Serum and...

Low dose oral ketamine treatment on post-traumatic stress disorder (PTSD) (OKTOP): An open-label pilot study

medRxiv Preprint Server November 26, 2024 Bonnie L. Quigley, Adem T. Can, Megan Dutton et al. 1 citation preprint

Ketamine is being actively investigated as a rapid-acting treatment for many conditions with a stress-related psychopathology, including post-traumatic stress disorder (PTSD). The majority of studies regarding ketamine treatment for PTSD to date (including open-label and randomised control trials) have focused on intravenous (IV) ketamine administration. This administration route has...

DOI: 10.1101/2024.11.26.24318024 (opens in new tab) Full text (opens in new tab) Low-dose oral ketamine PTSD Treatment PTSD Therapy PTSD Relief +8

Resting-State Electroencephalogram Complexity Is Associated With Oral Ketamine Treatment Response: A Bayesian Analysis of Lempel-Ziv Complexity and Multiscale Entropy.

Brain and Behavior November 1, 2024 Jules S Mitchell, Toomas E Anijärv, Adem T. Can et al.

Subanesthetic doses of ketamine are a promising novel treatment for suicidality; however, the evidence for predictive biomarkers is sparse. Recently, measures of complexity, including Lempel-Ziv complexity (LZC) and multiscale entropy (MSE), have been implicated in ketamine's therapeutic action. We evaluated electroencephalogram (EEG)-derived LZC and MSE differences between responders and...

DOI: 10.1002/brb3.70166 (opens in new tab) Full text (opens in new tab) Complexity Electroencephalogram Suicidality Ketamine therapy +4

Oral ketamine effects on dynamics of functional network connectivity in patients treated for chronic suicidality.

European Archives of Psychiatry and Clinical Neuroscience May 21, 2024 Zack Y Shan, Adem T. Can, Abdalla Z Mohamed et al. 3 citations

The underlying brain mechanisms of ketamine in treating chronic suicidality and the characteristics of patients who will benefit from ketamine treatment remain unclear. To address these gaps, we investigated temporal variations of brain functional synchronisation in patients with suicidality treated with ketamine in a 6-week open-label oral ketamine trial. The trial's primary endpoint was the...

DOI: 10.1007/s00406-024-01831-x (opens in new tab) Full text (opens in new tab) Chronic suicidality Dynamic functional connectivity Neural networks FMRI +5

Oral ketamine may offer a solution to the ketamine conundrum

Psychopharmacology December 1, 2023 Megan Dutton, Adem T. Can, Jim Lagopoulos et al.

Abstract Ketamine has received considerable attention for its rapid and robust antidepressant response over the past decade. Current evidence, in clinical populations, predominantly relates to parenterally administered ketamine, which is reported to produce significant undesirable side effects, with additional concerns regarding long-term safety and abuse potential. Attempts to produce a...

Ketamine and Zinc: Treatment of Anorexia Nervosa Via Dual NMDA Receptor Modulation

CNS Drugs January 22, 2023 Jules S Mitchell, Daniel Francis Hermens, Maxwell R. Bennett et al. 15 citations

Anorexia nervosa is a disorder associated with serious adverse health outcomes, for which there is currently considerable treatment ineffectiveness. Characterised by restrictive eating behaviours, distorted body image perceptions and excessive physical activity, there is growing recognition anorexia nervosa is associated with underlying dysfunction in excitatory and inhibitory neurometabolite...

A unique case of very low‐dose subcutaneous ketamine use: Maintenance option of ketamine for treatment‐resistant depression

Clinical Case Reports December 1, 2022 Adem T. Can, Daniel F. Hermens, Jim Lagopoulos 6 citations

Abstract Numerous studies have demonstrated that low‐dose subanesthetic intravenous ketamine infusion treatment leads to rapid improvement of treatment‐resistant depression. The following case report describes the use of a very low‐dose subcutaneous ketamine as a form of maintenance in a patient with severe treatment‐resistant depression using a retrospective chart review.

Molecular mechanisms underlying the N-methyl-d-aspartate receptor antagonists: Highlighting their potential for transdiagnostic therapeutics.

Progress in Neuro-Psychopharmacology and Biological Psychiatry July 1, 2022 Christina Driver, Timothy N. W. Jackson, Jim Lagopoulos et al.

The so-called "psychedelic renaissance" has stimulated expanded interest in several classes of drugs that appear to possess transdiagnostic effects in the treatment of mental health disorders, specifically. N-methyl-d-aspartate receptor (NMDAR) antagonists are one such class with diverse therapeutic potential. NMDARs mediate excitatory postsynaptic signalling in the central nervous system (CNS)...

The effect of mindfulness training on resting-state networks in pre-adolescent children with sub-clinical anxiety related attention impairments.

Brain Imaging and Behavior May 18, 2022 Michelle Kennedy, Abdalla Z Mohamed, Paul Schwenn et al.

Mindfulness training has been associated with improved attention and affect regulation in preadolescent children with anxiety related attention impairments, however little is known about the underlying neurobiology. This study sought to investigate the impact of mindfulness training on functional connectivity of attention and limbic brain networks in pre-adolescents. A total of 47 children with...

Neural changes in early visual processing after 6 months of mindfulness training in older adults

Scientific Reports December 3, 2020 Ben Isbel, Jan Weber, Jim Lagopoulos et al. 19 citations

Mindfulness has been shown to improve attentional performance, which is known to decline in aging. Long-latency electroencephalographic (EEG) event-related potential (ERP) changes have been reported immediately after mindfulness training, however the enduring stability of these effects is unknown. Furthermore, the ability of mindfulness to impact earlier stages of information processing is...

Nondirective meditation activates default mode network and areas associated with memory retrieval and emotional processing.

Frontiers in Human Neuroscience February 26, 2014 Jian Xu, Alexandra Vik, Inge R Groote et al.

Nondirective meditation techniques are practiced with a relaxed focus of attention that permits spontaneously occurring thoughts, images, sensations, memories, and emotions to emerge and pass freely, without any expectation that mind wandering should abate. These techniques are thought to facilitate mental processing of emotional experiences, thereby contributing to wellness and stress...

Increased theta and alpha EEG activity during nondirective meditation.

The Journal of Alternative and Complementary Medicine November 2009 Jim Lagopoulos, Jian Xu, Inge Rasmussen et al.

In recent years, there has been significant uptake of meditation and related relaxation techniques, as a means of alleviating stress and maintaining good health. Despite its popularity, little is known about the neural mechanisms by which meditation works, and there is a need for more rigorous investigations of the underlying neurobiology. Several electroencephalogram (EEG) studies have...